EvokAI Creative Labs’ Movement Disorder Monitor (MDM) Flex Sensor — which uses artificial intelligence (AI) in monitoring abnormal body…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Exposure to an air pollutant called fine particular matter (PM2.5) is significantly associated with an increased risk of developing…
Opal, Clario’s wearable sensor device, was shown to detect early motor progression in people with Parkinson’s disease more…
Levels of the protein prosaposin, known as PSAP, are altered in the brains of people with Parkinson’s disease, and…
Adults with Parkinson’s disease are willing to take additional medicine to manage daily off times — when the benefits…
Newer glucose-lowering drugs used to treat type 2 diabetes, compared with a placebo, appear to lower a person’s risk of…
Pupil light reflex (PLR), the automatic contraction or dilation of the eye’s pupil in response to light levels, was found…
Significant alterations in the structure and function of the eye’s retina — the layer at the very back of the…
People with Parkinson’s disease whose electrical brain wave activity declines more slowly during deep sleep develop levodopa-induced dyskinesia (LID),…
Future Leaders in Canadian Brain Research, a Brain Canada program, has awarded two early-career scientists CA$100,000 (about $74,180) each…